276 results on '"Sparchez, Zeno"'
Search Results
2. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma
3. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
4. SAT-525 Revolutionizing post-surgical outcome predictions: non-invasive tests and AI for hepatocellular carcinoma patients
5. Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma
6. Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?
7. Real-Time Contrast-Enhanced–Guided Biopsy Compared with Conventional Ultrasound–Guided Biopsy in the Diagnosis of Hepatic Tumors on a Background of Advanced Chronic Liver Disease: A Prospective, Randomized, Clinical Trial
8. Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis
9. Ultrasound of the chest
10. Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View
11. Comments and illustrations of the WFUMB CEUS liver guidelines: Rare benign focal liver lesion, part I
12. Progression of cirrhosis is not associated with clinically significant alterations in hemostasis assessed by thromboelastography
13. Ultrasound predictors of hemodynamic TIPS dysfunction: friends or foes?
14. EUS Needle Identification Comparison and Evaluation study (with videos)
15. Enhanced diagnosis and prognosis of severe alcoholic hepatitis using novel metabolomic biomarkers
16. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients
17. Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesions - non-infectious, non-neoplastic
18. The added value of CEUS and ultrasound-guided biopsy in diagnosing an aggressive desmoplastic small round cell tumour of peritoneum in a young male. A case report
19. PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma
20. Endoscopic Ultrasound-Guided Fine-Needle Biopsy versus Fine-Needle Aspiration in the Diagnosis of Focal Liver Lesions: Prospective Head-to-Head Comparison
21. Clinical Utility of the Contrast-Enhanced Endoscopic Ultrasound Guided Fine Needle Aspiration in the Diagnosis of Pancreatic Cyst
22. Outcome of liver cancer patients with SARS‐CoV‐2 infection: an international, multicentre, cohort study
23. Outcome of liver cancer patients with SARS-CoV-2 infection
24. NanoView EV Chip-based profiling in liver cancer differentiation-HCC from intrahepatic CCA-small EVs vs large EVs
25. Trusting your gut-a new direction in multikinase inhibitors therapy in hepatocellular carcinoma
26. Pulmonary complications of portal hypertension: The overlooked decompensation
27. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
28. Cholangiocarcinoma landscape in Europe:Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
29. Contrast enhancement for ultrasound-guided interventions:when to use it and what to expect?
30. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
31. Contrast enhanced endoscopic ultrasound in the diagnosis of pancreatic metastases
32. Contrast enhancement for ultrasound-guided interventions: when to use it and what to expect?
33. Old versus New – Tumor Ablation versus Tumor Nanoablation with Particular Emphasis on Liver Tumors
34. Navigating through the Lipid Metabolism Maze: Diagnosis and Prognosis Metabolites of Hepatocellular Carcinoma versus Compensated Cirrhosis
35. Direct Comparison of Elastography Endoscopic Ultrasound Fine-Needle Aspiration and B-Mode Endoscopic Ultrasound Fine-Needle Aspiration in Diagnosing Solid Pancreatic Lesions
36. DYNAMICS OF PORTAL VEIN VELOCITY – A POTENTIALLY USEFUL TOOL FOR DETECTING CLINCALLY SILENT TIPS DYSFUNCTION
37. Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
38. Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?
39. Trusting your gut-a new direction in multikinase inhibitors therapy in hepatocellular carcinoma
40. Hepatic Hydrothorax—An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
41. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed
42. Viscoelastic tests in liver disease: where do we stand now?
43. CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
44. Gastrointestinal Ultrasound in Functional Disorders of the Gastrointestinal Tract - EFSUMB Consensus Statement
45. Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study
46. SAT-519 - Ultrasound predictors of hemodynamic TIPS dysfunction: friends or foes?
47. WED-337 - Progression of cirrhosis is not associated with clinically significant alterations in hemostasis assessed by thromboelastography
48. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed.
49. Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
50. Complex ultrasound evaluation of non-alcoholic fatty liver disease. “One stop shop” with new ultrasound-based techniques.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.